Brooks, Moore & Associates, Inc. Bristol Myers Squibb CO Transaction History

Brooks, Moore & Associates, Inc.

$168 Million
Q3 2024

A detailed history of Brooks, Moore & Associates, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Brooks, Moore & Associates, Inc. holds 7,144 shares of BMY stock, worth $412,637. This represents 0.22% of its overall portfolio holdings.

Number of Shares

7,144

Previous 7,159 0.21%

Holding current value

$412,637

Previous $297,000 24.24%

% of portfolio

0.22%

Previous 0.19%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $594 - $776	-15 Reduced 0.21%	7,144 $369,000
Q3 2023 Nov 15, 2023	SELL	$57.89 - $64.73 $440,832 - $492,918	-7,615 Reduced 51.54%	7,159 $416,000
Q2 2023 Aug 15, 2023	SELL	$63.71 - $70.74 $29,943 - $33,247	-470 Reduced 3.08%	14,774 $945,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $55,524 - $62,977	845 Added 5.87%	15,244 $1.06 Million
Q4 2022 Feb 03, 2023	BUY	$68.48 - $81.09 $29,104 - $34,463	425 Added 3.04%	14,399 $1.04 Million
Q1 2022 May 03, 2022	SELL	$61.48 - $73.72 $56,869 - $68,191	-925 Reduced 6.21%	13,974 $1.02 Million
Q4 2021 Feb 04, 2022	SELL	$53.63 - $62.52 $803,377 - $936,549	-14,980 Reduced 50.14%	14,899 $929,000
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $9,940 - $11,644	168 Added 0.57%	29,879 $1.77 Million
Q2 2021 Jul 21, 2021	BUY	$61.91 - $67.42 $284,786 - $310,132	4,600 Added 18.32%	29,711 $1.99 Million
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $49,608 - $55,794	836 Added 3.44%	25,111 $1.59 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $40,418 - $45,801	700 Added 2.97%	24,275 $1.51 Million
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $108,542 - $120,279	1,890 Added 8.72%	23,575 $1.42 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $231,450 - $270,587	4,222 Added 24.18%	21,685 $1.28 Million
Q1 2020 Apr 22, 2020	BUY	$46.4 - $67.43 $82,128 - $119,351	1,770 Added 11.28%	17,463 $973,000
Q4 2019 Jan 30, 2020	SELL	$49.21 - $64.19 $125,239 - $163,363	-2,545 Reduced 13.95%	15,693 $1.01 Million
Q3 2019 Oct 25, 2019	BUY	$42.77 - $50.71 $137,933 - $163,539	3,225 Added 21.48%	18,238 $925,000
Q2 2019 Aug 09, 2019	BUY	$44.62 - $49.34 $33,018 - $36,511	740 Added 5.18%	15,013 $681,000
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $695,951 - $902,481	14,273 New	14,273 $742,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brooks, Moore & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brooks, Moore & Associates, Inc. with notifications on news.

Account

Brooks, Moore & Associates, Inc. Bristol Myers Squibb CO Transaction History